We are live on ! Find out more
ACL

APEIRON Capital Ltd Portfolio holdings

AUM $156M
1-Year Est. Return 183.17%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+183.17%
3 Year Est. Return
+486.87%
5 Year Est. Return
+343.15%
10 Year Est. Return
–
AUM
$68M
AUM Growth
-$81.4M
Cap. Flow
-$9.19M
Cap. Flow %
-13.51%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
3
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$1.29M
2
ONON icon
On Holding
ONON
+$1.29M
3
SQQQ icon
ProShares UltraPro Short QQQ
SQQQ
+$268K

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$7.52M
2
NVO
Novo Nordisk
NVO
+$3.41M
3
ASML icon
ASML
ASML
+$1.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 55.94%
2 Healthcare 25.82%
3 Communication Services 10.68%
4 Technology 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONON icon
1
On Holding
ONON
$9.86B
$29.3M 43.05%
1,085,922
+47,229
+5% +$1.29M
STAA icon
2
STAAR Surgical
STAA
$1.17B
$11M 16.13%
351,712
– –
PDD icon
3
Pinduoduo
PDD
$124B
$8.77M 12.9%
59,970
-62,000
-51% -$7.52M
NTES icon
4
NetEase
NTES
$78.7B
$7.26M 10.68%
77,983
– –
WOLF icon
5
Wolfspeed
WOLF
$1.29B
$4.43M 6.52%
101,895
– –
SWAV
6
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$3.49M 5.13%
18,300
– –
MRNA icon
7
Moderna
MRNA
$55.4B
$3.1M 4.56%
31,200
+15,300
+96% +$1.29M
SQQQ icon
8
ProShares UltraPro Short QQQ
SQQQ
$1.9B
$710K 1.04%
2,112
+616
+41% +$268K
ASML icon
9
ASML
ASML
$668B
– –
-1,875
Closed -$1.1M
NVO
10
Novo Nordisk
NVO
$207B
– –
-37,484
Closed -$3.41M

Similar funds

RWC
Rare Wolf Capital Bellevue, Washington $156M AUM
SC
Settian Capital New York $156M AUM 14.17% 1-Year Est. Return
JAA
Joel Adams & Associates Asheville, North Carolina $156M AUM 15.16% 1-Year Est. Return
BF
Bonfire Financial Colorado Springs, Colorado $156M AUM 18.12% 1-Year Est. Return
FLP
Financial Life Planners Tempe, Arizona $156M AUM 23.26% 1-Year Est. Return
RB
Renasant Bank Tupelo, Mississippi $156M AUM 21.58% 1-Year Est. Return
CP
Clarendon Private Boston, Massachusetts $156M AUM 32.94% 1-Year Est. Return
CWM
Clearview Wealth Management Irvine, California $156M AUM

APEIRON Capital Ltd's Q4 2023 Portfolio in Review

As of Q4 2023, APEIRON Capital Ltd held 10 positions worth $68M, down 54% from $149M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

APEIRON Capital Ltd withdrew a net $9.19M in Q4 2023, closing 2 positions and reducing 1 holding. Its most notable exit was Novo Nordisk, an estimated $3.41M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 56% of assets, up from 27% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, APEIRON Capital Ltd added an estimated $1.29M to Moderna.

  • APEIRON Capital Ltd added most to Moderna in Q4 2023, an estimated $1.29M increase.
  • APEIRON Capital Ltd's biggest Q4 2023 reduction was Pinduoduo, cutting an estimated $7.52M.
  • APEIRON Capital Ltd fully exited Novo Nordisk in Q4 2023, selling an estimated $3.41M.
  • APEIRON Capital Ltd's ten largest holdings make up 100% of its $68M portfolio in Q4 2023.
  • APEIRON Capital Ltd opened 0 new positions and closed 2 in Q4 2023.
  • APEIRON Capital Ltd's portfolio value fell 54% quarter-over-quarter to $68M.

Based on APEIRON Capital Ltd's 13F filing for Q4 2023, filed 1 Feb 2024.